Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ORAMED PHARMACEUTICALS INC. | Director | Common Stock | 46.7K | $103K | $2.21 | Mar 21, 2022 | Direct |
Quantum-Si Inc | Director | Stock Option (right to buy) | 113K | May 16, 2024 | Direct | ||
ELUTIA INC. | Director, 10%+ Owner | Stock Option (Right to Buy) | 47.8K | Jun 6, 2024 | Direct | ||
ORAMED PHARMACEUTICALS INC. | Director | Stock Option (right to buy) | 0 | Feb 17, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELUT | ELUTIA INC. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director, 10%+ Owner |
QSI | Quantum-Si Inc | May 16, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
QSI | Quantum-Si Inc | May 12, 2023 | 1 | $0 | 4 | May 16, 2023 | Director |
QSI | Quantum-Si Inc | Dec 20, 2022 | 1 | $0 | 4 | Dec 22, 2022 | Director |
QSI | Quantum-Si Inc | Dec 15, 2022 | 1 | -$191K | 4 | Dec 16, 2022 | Director |
QSI | Quantum-Si Inc | May 11, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
ORMP | ORAMED PHARMACEUTICALS INC. | Mar 21, 2022 | 1 | -$94.1K | 4 | Mar 22, 2022 | Director |
ORMP | ORAMED PHARMACEUTICALS INC. | Feb 17, 2022 | 3 | $5.30 | 4 | Feb 22, 2022 | Director |
ORMP | ORAMED PHARMACEUTICALS INC. | Feb 11, 2022 | 1 | $0 | 4/A | Feb 15, 2022 | Director |
ORMP | ORAMED PHARMACEUTICALS INC. | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Director |
QSI | Quantum-Si Inc | Dec 31, 2021 | 1 | $0 | 5 | Feb 10, 2022 | Director |
ORMP | ORAMED PHARMACEUTICALS INC. | Dec 16, 2021 | 1 | $0 | 4 | Dec 17, 2021 | Director |
ORMP | ORAMED PHARMACEUTICALS INC. | Sep 16, 2021 | 1 | -$443K | 4 | Sep 20, 2021 | Director |
ORMP | ORAMED PHARMACEUTICALS INC. | Aug 31, 2021 | 1 | $0 | 4 | Sep 2, 2021 | Director |
ORMP | ORAMED PHARMACEUTICALS INC. | Aug 9, 2021 | 12 | $14.00 | 4 | Aug 11, 2021 | Director |
QSI | Quantum-Si Inc | Jun 10, 2021 | 2 | $19M | 4 | Jun 15, 2021 | Director |